Marcelina Rybiańska

Marcelina Rybiańska began their work experience in the regulatory affairs field in 2007 at i3 Research, where they held various roles including Regulatory Affairs Associate and Regulatory Affairs Associate II until 2011. From 2011 to 2012, they worked as a Senior Regulatory Affairs Associate at PharmaNet/i3. In 2012, they joined Worldwide Clinical Trials and progressed from Senior Regulatory Affairs Specialist to Manager, Global Regulatory Affairs, to Senior Manager, Global Regulatory Affairs. Marcelina'smost recent role at Worldwide Clinical Trials was as Associate Director, Global Regulatory Affairs from 2018 to 2021. Currently, Marcelina is employed at ERGOMED as the Regulatory Affairs Associate Director, Strategy, and has been promoted to the position of Director, Regulatory Affairs, Strategy in April 2022.

Marcelina Rybiańska completed their Master of Arts degree at the University of Wroclaw from 2003 to 2007. Marcelina also attended the University of Oslo in 2006-2007.